Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 6 | BMC Complementary and Alternative Medicine

Fig. 6

From: A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial

Fig. 6

Bacteroidetes and Firmicutes relative abundances within the total cohort (a) and the two subgroups, severe (b) and moderate (c) that have been treated either with placebo or EpiCor. Each box represents median (50th percentile) and interquartile range (25th and 75th percentiles). The symbol (+) represents the mean. The outliers are indicated as dots (Tukey method). Significant (p < 0.05) and nearly significant (p < 0.1) p-values are also indicated within the boxplots (two-way repeated measures ANOVA with Dunnett’s multiple comparison’s test against V1). The inner plots (a*, b* and c*) correspond to the calculated Firmicutes/Bacteroidetes (F/B) ratio at each visit within the two treatment groups. Legend: V1, V2 and V3 correspond to visit 1 (baseline), visit 2 (3-weeks after treatment) and visit 3 (6-weeks after treatment), respectively

Back to article page